Publisher： Bentham Science Publishers
E-ISSN： 1873-4286|17|38|4379-4385
ISSN： 1381-6128
Source： Current Pharmaceutical Design, Vol.17, Iss.38, 2011-01, pp. : 4379-4385
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
By Roges Octaviano A Baron Marilyn Philis-Tsimikas Athena
Expert Opinion on Investigational Drugs, Vol. 14, Iss. 6, 2005-06 ,pp. :
Access to resources
Recommend
Targeting amyloid-beta by glucagon-like peptide -1 (GLP-1) in Alzheimer's disease and diabetes
By Bak Ann Mosegaard Egefjord Lærke Gejl Michael Steffensen Charlotte Stecher Chalotte Willemann Smidt Kamille Brock Birgitte Rungby Jørgen
Expert Opinion on Therapeutic Targets, Vol. 15, Iss. 10, 2011-10 ,pp. :
Potential Role of Glucagon-Like Peptide-1 (GLP-1) in Neuroprotection
CNS Drugs, Vol. 26, Iss. 10, 2012-10 ,pp. :
Cardiovascular Effects of Glucagon-Like Peptide 1
Mini Reviews in Medicinal Chemistry, Vol. 11, Iss. 1, 2011-01 ,pp. :